Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Graph

BCLI Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $963.00K; Operating expenses (m); Income tax (m); Net income -$3.85M.
  • 2026-03-31: Research and development $762.00K; Operating expenses (m); Income tax (m); Net income -$2.13M.
  • 2025-12-31: Research and development $852.00K*; Operating expenses (m); Income tax (m); Net income -$2.43M*.
  • 2025-09-30: Research and development $899.00K; Operating expenses (m); Income tax (m); Net income -$2.11M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$963.00K(m)(m)-$3.85M
2026-03-31$762.00K(m)(m)-$2.13M
2025-12-31$852.00K*(m)(m)-$2.43M*
2025-09-30$899.00K(m)(m)-$2.11M
2025-06-30$1.12M(m)(m)-$2.90M
2025-03-31$1.30M(m)(m)-$2.86M
2024-09-30$1.04M(m)(m)-$2.71M
2024-06-30$922.00K(m)(m)-$2.54M
2024-03-31$961.00K(m)(m)-$3.40M
2023-09-30$3.33M(m)(m)-$1.23M
2023-06-30$2.79M(m)(m)-$5.33M
2023-03-31$2.92M(m)(m)-$5.06M
2022-09-30$3.78M(m)(m)-$6.86M
2022-06-30$5.11M(m)(m)-$7.04M
2022-03-31$2.62M(m)(m)-$5.36M
2021-09-30$3.62M(m)(m)-$5.34M
2021-06-30$3.60M(m)(m)-$6.27M
2021-03-31$4.34M(m)(m)-$6.66M
2020-09-30$1.87M(m)(m)-$4.49M
2020-06-30$5.69M(m)(m)-$7.39M
2020-03-31$5.95M(m)(m)-$8.11M
2019-09-30$4.01M(m)(m)-$5.63M
2019-06-30$3.55M(m)(m)-$4.90M
2019-03-31$3.46M(m)(m)-$5.03M
2018-09-30$1.98M(m)(m)-$3.18M
2018-06-30$1.48M(m)(m)-$3.09M
2018-03-31$977.00K(m)(m)-$2.30M
2017-09-30$1.17M(m)(m)-$2.40M
2017-06-30$435.00K(m)(m)-$1.04M
2017-03-31$941.00K(m)(m)-$1.78M
2016-09-30$790.00K(m)(m)-$1.61M
2016-06-30$151.00K(m)(m)-$962.00K
2016-03-31$986.00K(m)(m)-$1.79M
2015-09-30$1.50M(m)(m)-$2.60M
2015-06-30$1.38M(m)(m)-$2.27M
2015-03-31$1.25M$2.21M$0.00-$2.24M
2014-12-31(m)$2.67M*(m)(m)
2014-09-30$1.57M$2.43M$2.00K-$2.42M
2014-06-30$877.00K$1.29M$0.00-$1.98M
2014-03-31$680.00K$1.03M$0.00-$2.11M
2013-09-30$804.00K$1.08M$1.00K-$1.08M
2013-06-30$742.00K$1.49M$18.00K-$1.52M
2013-03-31$522.00K$1.08M$0.00-$1.08M
2012-09-30$732.00K$1.17M$0.00-$1.15M
2012-06-30$385.00K$833.00K$1.00K-$830.00K
2012-03-31$369.00K$879.00K$4.00K-$872.00K
2011-09-30$176.00K$740.00K$0.00-$694.00K
2011-06-30$586.00K$1.42M-$5.00K$1.10M
2011-03-31$270.00K$528.00K$0.00-$705.00K
2010-09-30$371.00K$635.00K-$24.00K$704.00K
2010-06-30-$348.00K-$616.00K$0.00$614.00K

Revenue and expense 6 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$1.73M(m)(m)-$5.98M
2025-06-30$2.42M(m)(m)-$5.77M
2024-06-30$1.88M(m)(m)-$5.94M
2023-06-30$5.72M(m)(m)-$10.39M
2022-06-30$7.73M(m)(m)-$12.40M
2021-06-30$7.94M(m)(m)-$12.93M
2020-06-30$11.64M(m)(m)-$15.51M
2019-06-30$7.01M(m)(m)-$9.93M
2018-06-30$2.46M(m)(m)-$5.39M
2017-06-30$1.38M(m)(m)-$2.83M
2016-06-30$1.14M(m)(m)-$2.75M
2015-06-30$2.62M(m)(m)-$4.50M
2014-06-30$1.56M$2.33M$0.00-$4.09M
2013-06-30$1.26M$2.57M$18.00K-$2.60M
2012-06-30$754.00K$1.71M$5.00K-$1.70M
2011-06-30$856.00K$1.94M-$5.00K$1.80M
2010-06-30-$587.00K-$1.23M$0.00$1.23M
2001-03-31(m)(m)(m)-$17.00K

Revenue and expense 9 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-09-30$3.32M(m)(m)-$7.87M
2024-09-30$2.93M(m)(m)-$8.65M
2023-09-30$9.05M(m)(m)-$11.61M
2022-09-30$11.51M(m)(m)-$19.26M
2021-09-30$11.56M(m)(m)-$18.27M
2020-09-30$13.51M(m)(m)-$20.00M
2019-09-30$11.02M(m)(m)-$15.56M
2018-09-30$4.43M(m)(m)-$8.56M
2017-09-30$2.54M(m)(m)-$5.23M
2016-09-30$1.93M(m)(m)-$4.36M
2015-09-30$4.12M(m)(m)-$7.10M
2014-09-30$3.13M$4.75M$2.00K-$6.52M
2013-09-30$2.07M$3.64M$19.00K-$3.68M
2012-09-30$1.49M$2.88M$5.00K-$2.85M
2011-09-30$1.03M$2.49M$5.00K-$2.50M
2010-09-30$958.00K$1.86M-$24.00K$1.93M
2006-12-31(m)(m)(m)-$3.92M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$4.17M(m)(m)-$10.31M
2024-12-31$4.65M(m)(m)-$11.62M
2023-12-31$10.75M(m)(m)-$17.19M
2022-12-31$13.96M(m)(m)-$24.28M
2021-12-31$15.23M(m)(m)-$24.46M
2020-12-31$22.33M(m)(m)-$31.81M
2019-12-31$17.20M(m)(m)-$23.25M
2018-12-31$8.29M(m)(m)-$13.95M
2017-12-31$977.00K(m)$0.00-$4.95M
2016-12-31$2.25M(m)$0.00-$4.98M
2015-12-31$4.95M(m)$0.00-$8.49M
2014-12-31$4.77M$7.42M$0.00-$9.25M
2013-12-31$2.92M$5.04M$0.00-$4.90M
2012-12-31$1.77M$3.52M$5.00K-$3.43M
2011-12-31$1.69M$3.89M$5.00K-$3.92M
2010-12-31$1.04M$2.59M-$19.00K-$2.42M
2009-12-31(m)(m)(m)-$1.78M
2008-12-31(m)(m)(m)-$3.47M
2007-12-31(m)(m)(m)-$6.24M
2006-03-31(m)(m)(m)-$3.32M
2005-03-31(m)(m)(m)-$18.84M
2004-03-31(m)(m)(m)-$73.00K
2003-03-31(m)(m)(m)-$47.00K
2002-03-31(m)(m)(m)-$26.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37